Johnson & Johnson said it asked the U.S. Food and Drug Administration (FDA) to authorize boosters for its coronavirus vaccine, but left the FDA and Centers for Disease Control and Prevention (CDC) to decide just who. should get their booster and when. “The process is not that we have asked for a very specific interval: we are providing them with data and we will present it to the committee. They will consider it and decide on an appropriate interval,” remarked Mathai Mammen, head of global research and development of the vaccines division of J&J. .
The FDA Vaccine Advisory Committee will meet on October 14 and 15 to consider requests from Moderna and Johnson & Johnson to add booster doses for their Covid-19 vaccines.